Mark Verrill
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
-
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in
- Oncology 46
- Cancer Treatment and Pharmacology 28
- HER2/EGFR in Cancer Research 20
- Peptidase Inhibition and Analysis 3
-
- Breast Cancer Treatment Studies 31
- Co-authors
- Chris Plummer (5 shared papers)Peter Canney (7 shared papers)Alison Jones (2 shared papers)L. A. Smith (1 shared paper)Gill Levitt (1 shared paper)Victoria Cornelius (1 shared paper)Alan V. Boddy (10 shared papers)Peter Barrett‐Lee (7 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Annals of Oncology (10 papers)European Journal of Cancer (8 papers)British Journal of Cancer (8 papers)Cancer Research (4 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Mark Verrill
81 papers receiving 2.5k citations
Mark Verrill's Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 1.0k
- Cardiology and Cardiovascular Medicine 661
- Cancer Research 360
- Pulmonary and Respiratory Medicine 537
- Radiology, Nuclear Medicine and Imaging 240
Countries citing papers authored by Mark Verrill
This map shows the geographic impact of Mark Verrill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Verrill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Verrill more than expected).
Fields of papers citing papers by Mark Verrill
This network shows the impact of papers produced by Mark Verrill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Verrill. The network helps show where Mark Verrill may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Verrill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials Hit paper breakdown → | 2010 | 565 |
| 2 | 2009 | 159 | |
| 3 | 2017 | 151 | |
| 4 | 2010 | 150 | |
| 5 | 2009 | 146 | |
| 6 | 2002 | 130 | |
| 7 | 1998 | 125 | |
| 8 | 2005 | 95 | |
| 9 | 2008 | 85 | |
| 10 | 1997 | 83 | |
| 11 | 2005 | 77 | |
| 12 | 2004 | 40 | |
| 13 | 1997 | 40 | |
| 14 | 2006 | 39 | |
| 15 | 2007 | 35 | |
| 16 | 2003 | 34 | |
| 17 | 2005 | 32 | |
| 18 | 2011 | 31 | |
| 19 | 2009 | 30 | |
| 20 | 2014 | 30 |
About Mark Verrill
Mark Verrill is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging, having authored 88 papers that have together received 2.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (31 papers), Cancer Treatment and Pharmacology (28 papers), HER2/EGFR in Cancer Research (20 papers), Advanced Breast Cancer Therapies (10 papers), Sarcoma Diagnosis and Treatment (7 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Oncology (1.0k citations), Cardiology and Cardiovascular Medicine (661 citations), Cancer Research (360 citations), Pulmonary and Respiratory Medicine (537 citations) and Radiology, Nuclear Medicine and Imaging (240 citations). Mark Verrill has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Chris Plummer, Peter Canney, Alison Jones, L. A. Smith, Gill Levitt, Victoria Cornelius, Alan V. Boddy, Peter Barrett‐Lee, David Jamieson and Andrew Wardley. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, British Journal of Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.